Trial intelligence / Profile preview

Vitamin C for treating major depressive disorder

IRCT201312263930N31Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of ascorbic acid in major depressive disorder (MDD), sponsored by Shiraz University of Medical Sciences. Started Sep 2013; status: completed.

02

Drugs

ascorbic acid
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on IRCT201312263930N31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201312263930N31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call